The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Ravi Misra - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst
: I hope the connection is okay, and I hope you guys and your families are okay. Tim, I think we're all trying to figure out kind of what kind of shape
this rebound is, and I appreciate that data is low, but it sounds like what you're saying is that procedures and scheduling is coming back online.
With regards to the backlog, I mean, is a reasonable way to think about it, you have these kind of 761 cases that have approvals, plus whatever
assumption of cases that you didn't think get done -- got done in 1Q as kind of the low-hanging fruit, so to speak, over the next couple of quarters?
And then as we work through the diagnostic process for new patients, you get kind of the volume growth to reaccelerate off that?
And then maybe secondly, I'm curious, as you get these operating rooms coming back online, just what procedures are you competing against? I
assume maybe to the lack of your satisfaction, they're not all Inspire procedures. But I'm just curious, what other surgeries do you think that the
hospital is going to have to go for? And how are you guys fighting to get your procedures done?
Question: Ravi Misra - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst
: Yes, great. I think you were a little bit more -- less diplomatic than I was asking the question, but I really appreciate the response, Tim.
Just one more on the kind of financial incentives for the hospital. The -- just curious, you got the add-on code for the lead for the surgeon fee now.
Is that something that the private insurer has also been paying for? I'm just curious about the work you need to do there to work beyond the
Medicare population on that.
|
